Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: J Thorac Oncol. 2023 May 18;18(9):1222–1232. doi: 10.1016/j.jtho.2023.05.008

Figure 4. APM gene signature as a correlate of survival.

Figure 4.

Kaplan-Meier curves of overall survival among patients treated with nivolumab only (left) and nivolumab plus ipilimumab (right), by tertiles of antigen presentation machinery (APM) gene expression signature. P values are for cox proportional hazards of OS as a function of APM gene signature.